Recall Register

Drug recall: ePHEDrine Sulfate Injection, USP 25 mg/5 mL (5 mg/mL) Single Use 5 mL Syringe, For IV, IM, or SC injection…

Class II FDA enforcement event 68336. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Labeling: Label Error on Declared Strength; The outer light protective bags, where the ephedrine sulfate injection syringes are stored, were mislabeled with 25 mg/mL in big font and 5 mg/mL in small font, however, the actual syringes were correctly labeled as 25 mg/5 mL.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

US Compounding Inc started this drug recall on 16 May 2014. The firm address in the FDA record is in Conway, AR. FDA put the recall in Class II. FDA event 68336 has 1 product record. The first FDA enforcement report date is 27 Aug 2014. The record gives the status Terminated, with the termination date 4 Nov 2014. 74 of the 313 drug events that started in 2014 have more product records. The median drug event of 2014 has 1 product record. The openFDA file has 313 drug events that started in 2014 and 370 that started in 2013.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Nationwide

Recalling firm

US Compounding Inc, Conway, AR.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 68336: product records
Recall numberProductQuantityClassStatusReport date
D-1548-2014ePHEDrine Sulfate Injection, USP 25 mg/5 mL (5 mg/mL) Single Use 5 mL Syringe, For IV, IM, or SC injection, Preservative Free, For Office/Hospital Use Only, Protect from Light, 62295-3084-05, US Compounding Pharmacy, Conway, AR 800-718-3588762 SyringesClass IITerminated27 Aug 2014

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Drug events that started in 2014
313
Share of these events in Class II
58%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
7

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 68336. https://recallregister.com/fda/ii/68336/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Nationwide
What quantity of product is in FDA event 68336?
The FDA record gives this quantity: 762 Syringes
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2014 have the same class?
58% of the 313 drug events that started in 2014 are in Class II.